Opportunity

Get Grant Funding and Private Investment for UK SMEs: Growth Catalyst Investor Partnerships Round Two (2026)

This opportunity is for UK micro, small, and medium-sized businesses that are ready for a serious growth push — and have caught the eye of an investor.

JJ Ben-Joseph
JJ Ben-Joseph
📅 Deadline Feb 3, 2026
🏛️ Source UKRI Opportunities
Apply Now

This opportunity is for UK micro, small, and medium-sized businesses that are ready for a serious growth push — and have caught the eye of an investor. The Growth Catalyst: Investor Partnerships Round Two pairs Innovate UK grant funding with private investment from a select pool of investor partners. If you already have an investor willing to back your idea and you want public grant funding to turbocharge that investment, this is the competition to know about.

Think of it like a matched-dressing for funding: the investor brings market confidence and capital, and Innovate UK brings non-dilutive grant funding and validation. That combination can accelerate product development, scale manufacturing, or open new markets — but it comes with a gatekeeper: you must be invited to apply by an investor from the programme’s approved pool. If you don’t have that invitation, you won’t get in the door.

Below I walk you through everything that matters: who is eligible, what the award actually offers, how to improve your odds of being selected by an investor, what reviewers will be looking for, common traps to avoid, a realistic timeline, and step-by-step application guidance so you can apply with confidence.

At a Glance

DetailInformation
OpportunityGrowth Catalyst: Investor Partnerships Round Two
FunderInnovate UK (part of UK Research and Innovation)
Funding typeGrant funding combined with private investor co-investment
Eligible applicantsUK-registered micro, small and medium-sized enterprises (SMEs)
Applicant modelSingle applicant only (no consortiums)
Geographic requirementProject work must be carried out in the UK; results exploited in or from the UK
Special conditionApplicant must have been invited to apply by an investor from the programme’s selected investor partners
StatusOpen
Deadline3 February 2026, 11:00 (UK time)
Official detailsSee Innovation Funding Service listing (link in How to Apply)

Why this opportunity matters (Introduction)

If you run a small or medium-sized business in the UK and your product or service is at the stage where private investors are interested, grant support that sits alongside that investment can change the trajectory of your company. Grants reduce the immediate cash burden for risky R&D or scale-up activities, while investor money signals commercial credibility. Together they create an environment where engineering and commercial milestones can be achieved faster.

This isn’t basic seed funding. The programme targets companies that have already attracted investor interest — which means the technical idea has shown promise and there’s a plausible route to market. The invitation requirement raises the bar: you’re not submitting a cold application to a panel, you’re entering through a door opened by an investor who’s already evaluated you on commercial potential.

Finally, Innovate UK backing carries reputational value. Beyond the cash, the award can open more conversations with customers, partners, and future investors. But don’t mistake prestige for easy money: this competition is selective, and success requires both a solid business case and tight project planning.

What This Opportunity Offers

This competition provides grant funding that runs alongside private capital from the programme’s investor partners. The public backing is intended to de-risk the project elements that are primarily technological or developmental, allowing the investor to focus their capital on commercial rollout and scaling. Practically, this can mean grants that cover prototyping, regulatory testing, demonstration projects, or technology de-risking activities, while private funds can be used for production, sales hires, or market expansion.

Because the grant is combined with investor funding, applications are judged not only on technical merit but on commercial progression and investor confidence. Expect the assessment to examine the coherence between what the grant will achieve (technology milestones, pilots, validation) and what the investor money will achieve (manufacturing scale, go-to-market, distribution). Programs like this are built to accelerate a project from “promising lab or prototype” to “commercially viable offering.”

You should also view this as a credibility amplifier. Innovate UK’s involvement signals to future partners and customers that an independent public body has validated part of your plan. That validation often helps in later fundraising rounds, procurement processes, or supplier negotiations.

Note: Full details on eligible costs, funding rates, and project duration are in the official Innovation Funding Service listing. Always confirm the specific financial rules on the official page before you budget.

Who Should Apply

This competition is for UK-registered micro, small and medium-sized enterprises (SMEs) that meet three practical conditions: your organisation is registered in the UK; the project work will take place in the UK; and you plan to exploit the results in or from the UK. Crucially, you must have been invited to apply by an investor from the programme’s approved investor partners.

A few concrete examples of good fits:

  • A medtech SME that has completed early feasibility prototypes and has an angel syndicate offering capital to run a regulatory study. The investor invites the SME to apply for grant funding to pay for the clinical validation that de-risks the regulatory pathway.
  • A deep-tech hardware startup with a lead investor willing to fund production tooling, while the Innovate UK grant would pay for scale-up engineering and pilot production trials at a UK facility.
  • A climate-tech SME with a Series A lead investor committed to follow-on funding for market entry, and the grant covers demonstration of the solution in a real-world customer environment.

If you’re an academic spin-out still seeking your first investor commitment, this is probably not the right competition yet. The investor invitation is the prerequisite; work first on securing that investor interest through accelerators, pitch days, investor introductions, or proof-of-concept milestones.

What You Need to Know About Eligibility (narrative)

The eligibility rules are straightforward but strict. Only single applicants are accepted — no partnerships, no subcontracting-led consortia as lead applicants. You must be an SME by UK definitions and be UK-registered. The project must physically happen in the UK and the commercial exploitation must be in or from the UK.

The non-negotiable showstopper is the investor invitation. Innovate UK will only accept applications from SMEs that have been specifically invited by one of the selected investor partners. That means your path to applying typically runs: get investor interest → be selected or invited by an investor partner → submit a Growth Catalyst application. If you don’t have that invitation, you can’t apply, no matter how strong your project might be.

Make sure you can prove the investor relationship: letters of intent, term sheet summaries, or other documentation that confirms the investor’s commitment and that the invitation was extended.

Insider Tips for a Winning Application (5–7 focused tips, 300+ words)

  1. Treat the investor as your co-author. Because the investor invited you, their view matters. Before you write a word of the application, have a conversation with them about what success looks like from their side. Ask them which milestones they want the grant to fund and which outcomes will make them release further capital. Don’t give reviewers and investors conflicting narratives.

  2. Show tight alignment between grant tasks and investor-funded activities. Imagine the application reviewers and investor partners are triangulating: grant funds should address technical risk; investor funds should address commercial scaling. Your budget and workplan must make that distinction crystal clear. If it looks like you’re asking both sources to pay for the same thing, you’ll raise red flags.

  3. Quantify commercial traction. Numbers matter: pilot customers, LOIs, revenue to date, unit economics, and realistic market sizing. Don’t inflate projections. If you claim a large market, show how you’ll capture a defensible slice within a clear timeframe.

  4. Build a realistic, milestone-driven plan. Convert your project into 3–6 tangible milestones with dates, success criteria, and deliverables. Funders like to see “we will achieve X by month 6, measured by Y.” That reduces perceived risk and makes the reviewers’ job easier.

  5. Document the investor invitation and commitment scope. Attach a short letter or email excerpt from the investor confirming the invitation, the intended level of investment, and what they expect the grant to fund. If you’re still negotiating terms, get a succinct statement of intent rather than ambiguous language.

  6. Address IP and exploitation honestly. If your project depends on a patent or confidential know-how, explain ownership, filing status, and exploitation plans. Reviewers want to know who owns the IP and how it will be used commercially.

  7. Run your application past non-technical readers. Investors and Innovate UK reviewers come from mixed backgrounds. If someone outside your specific field can understand the core problem, proposed solution, and why the grant is needed, you’re on the right track.

These tips are practical because this competition is not just about technical brilliance — it’s about matching technical progress with investor readiness. Make the link between the two obvious.

Application Timeline (realistic schedule working backward from the deadline)

The deadline is 3 February 2026 at 11:00. Start at least 8–10 weeks before that date to leave room for investor sign-off and institutional checks.

  • 10 weeks out: Confirm investor invitation and get a written statement from them. Begin drafting your project summary and high-level budget.
  • 8 weeks out: Draft the full application narrative and workplan. Circulate to the investor for alignment. Start collecting any mandatory documents (company registration, financial statements).
  • 6 weeks out: Finalise the budget with your finance team or accountant. Get the investor letter updated to reflect the agreed usage of grant and private funds.
  • 4 weeks out: Have at least two external reviewers read your application — one technical and one commercial. Revise based on feedback.
  • 2 weeks out: Final proofreading, formatting checks, and ensure uploaded documents meet file-type and size restrictions. Confirm any required institutional sign-off if your company requires internal approvals.
  • 48–72 hours before deadline: Submit. Don’t wait for the last hour. Technical systems can fail and deadlines are enforced strictly.

If you’re being supported by a professional grant writer or consultant, build them into this schedule early so they can shape the narrative rather than patch the application at the end.

Required Materials (what to prepare and how to present them)

Although the Innovation Funding Service listing has the definitive checklist, expect to prepare the following materials and to present them clearly:

  • Project description and technical plan: 3–10 pages depending on requirements. Use clear milestones and measurable outcomes.
  • Detailed budget and budget justification: Align the grant-funded costs with the technical milestones. Be explicit about which costs are covered by the investor.
  • Evidence of investor invitation/commitment: A concise letter or email confirming the invitation and outlining the expected level or nature of investment.
  • Company registration and financials: Up-to-date UK company registration details and basic financial statements (cash flow, balance sheet, or forecasts). Reviewers want to see that your business is viable.
  • Project team CVs or bios: Short biographies focusing on roles and relevant experience for those executing the project.
  • Intellectual property statement: Explain ownership, filing status, and exploitation plans.
  • Risk register and mitigation plan: Identify the main technical and commercial risks and how you will reduce them.
  • Any supporting letters (e.g., pilot customers or supply partners): Short, specific letters are better than generous but vague ones.

When preparing documents, make them readable: use headings, short paragraphs, and clear metrics. Avoid dense technical jargon unless it directly supports a milestone.

What Makes an Application Stand Out

Reviewers here are juggling technical credibility and commercial logic. The standout applications marry both seamlessly. That means your technical plan must be plausible and well-structured, while the commercial story — how the product will reach customers and return value to the investor — must be credible.

Excellent applications also demonstrate investor alignment: letters that don’t just say “we support this” but detail what the investor commits to and why the project merits grant support. Showing that the investor is prepared to fund specific downstream activities (manufacturing, sales, customer trials) while the grant funds the technical de-risking creates a persuasive narrative.

Clarity on metrics and milestones is another differentiator. If you can show specific, measurable targets — e.g., reduce unit cost to X, complete third-party lab validation, sign 3 pilot customers — and attach dates, reviewers can visualize progress and impact.

Finally, outstanding applications are realistic about risk. Instead of pretending nothing can go wrong, they identify primary risks and provide contingency plans. That honesty signals competence and increases reviewer trust.

Common Mistakes to Avoid (with fixes)

  1. Waiting to align with the investor late in the process. Fix: Get a written statement from the investor early and confirm that they understand and agree with the grant’s role.
  2. Asking for overlapping funding for the same costs from both grant and investor. Fix: Clearly separate costs and annotate the budget to show which fund covers what.
  3. Overly technical applications that leave reviewers wondering why this matters commercially. Fix: Add a clear commercial summary that explains customers, revenue model, and path to scale in plain language.
  4. Underestimating timelines and budgets. Fix: Build conservative schedules and include contingency buffers for testing delays or supplier issues.
  5. Poor documentation of UK location requirements. Fix: Provide clear statements about where the work will be done and how exploitation will be UK-focused.
  6. Weak or vague investor letters. Fix: Secure a succinct letter that states the investment intent, approximate amount (if possible), and the investor’s expectations for the grant-funded work.

Address these early and you’ll remove the most common objections reviewers raise.

Frequently Asked Questions

Q: Can international companies apply?
A: No. The applicant must be a UK-registered micro, small or medium-sized enterprise and the project work must be carried out in the UK. Exploitation should occur in or from the UK.

Q: Do I need to have an investor already signed on to apply?
A: You need an invitation from an investor partner in the programme’s selected pool. That invitation typically follows investor interest or a decision to consider co-investment. Confirm the process with your investor contact.

Q: Can universities or research organisations lead projects?
A: No. This competition is intended for single SME applicants only. Academic or research institutions can be subcontractors where allowed, but they cannot be the lead applicant.

Q: What costs can the grant cover?
A: Specific eligible costs and funding rates are listed on the official Innovation Funding Service page. Generally grant funds focus on R&D and de-risking activities, while investor funds support commercial scaling, but always check the official guidance.

Q: How strict is the deadline?
A: Very strict. Submit well ahead of the deadline to avoid technical problems. Deadlines are enforced.

Q: Will Innovate UK publish the list of investor partners?
A: The investor partners and their participation details are usually published in the programme documentation. If you’re unsure, check the Innovation Funding Service page or ask your investor contact.

Q: Can I apply if the investor has not yet committed funds but has expressed interest?
A: You need an invitation from a selected investor partner. The nature of that invitation matters — if it’s an explicit invitation to apply contingent on further due diligence, document that clearly. Ambiguous expressions of interest are risky.

Next Steps — How to Apply

Ready to move forward? Start with a single pragmatic step: speak to the investor who invited you to apply and agree, in writing, which project parts the grant will fund and which the investor will fund. That alignment makes the application straightforward.

Then prepare the core documents: project narrative with clear milestones, a detailed budget and justification, investor invitation letter, team bios, and proof of UK registration. Run the draft by someone who isn’t in your technical bubble — a commercial advisor or an investor associate — to ensure clarity.

Finally, visit the official opportunity page for the full rules, deadlines, and submission portal. That page is the authoritative source for funding rates, eligible costs, and document formats.

How to Apply / Get Started

Ready to apply? Visit the official opportunity page for full details and application submission:
Apply now: https://www.ukri.org/opportunity/growth-catalyst-investor-partnerships-round-two/

If you have specific questions about eligibility or the investor list, check the FAQ on the official page or contact the programme officers listed there. Good applications often begin with one short conversation — about investor alignment — so don’t delay that call.


This competition rewards strong technical plans, but only when they sit inside a coherent commercial roadmap backed by an investor partner. If you can present that combination — a credible investor, clear milestones to reduce technical risk, and a realistic plan to exploit the results in the UK — you’ll be giving reviewers everything they need to say yes. Good luck.